| # | Drug | Count |
|---|---|---|
| 0 | SILDENAFIL CITRATE | 49 |
| 1 | SILDENAFIL | 47 |
| 2 | SILDENAFIL POWDER, | 43 |
| 3 | DIAZEPAM | 29 |
| 4 | DIAZEPAM ORAL | 27 |
| 5 | DIAZEPAM ORAL SOLUTION (CONCENTRATE) | 27 |
| 6 | ZOLPIDEM TARTRATE | 26 |
| 7 | PREGABALIN | 20 |
| 8 | FENTANYL | 19 |
| 9 | OXYCODONE | 19 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COCAINE HYDROCHLORIDE | 1 | 0.0026 |
| 1 | SILDENAFIL POWDER, | 43 | 0.0012 |
| 2 | DICLOXACILLIN SODIUM | 1 | 0.0011 |
| 3 | CARBOXYMETHYLCELLULOSE SODIUM | 3 | 0.0005 |
| 4 | SILDENAFIL CITRATE | 49 | 0.0004 |
| 5 | MODAFINIL | 11 | 0.0003 |
| 6 | DIAZEPAM ORAL | 27 | 0.0003 |
| 7 | METHYLPHENIDATE HYDROCHLORIDE | 16 | 0.0003 |
| 8 | ETONOGESTREL AND ETHINYL ESTRADIOL | 6 | 0.0003 |
| 9 | GAUNFACINE | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Phosphodiesterase 5 Inhibitor [EPC] | 49 |
| 1 | Benzodiazepine [EPC] | 35 |
| 2 | Atypical Antipsychotic [EPC] | 19 |
| 3 | Opioid Agonist [EPC] | 19 |
| 4 | Central Nervous System Stimulant [EPC] | 14 |
| 5 | Progestin [EPC] | 11 |
| 6 | Sympathomimetic-like Agent [EPC] | 11 |
| 7 | 5-alpha Reductase Inhibitor [EPC] | 7 |
| 8 | Anti-epileptic Agent [EPC] | 6 |
| 9 | Estrogen [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Phosphodiesterase 5 Inhibitor [EPC] | 49 | 0.0004 |
| 1 | Sympathomimetic-like Agent [EPC] | 11 | 0.0003 |
| 2 | Central Nervous System Stimulant [EPC] | 14 | 0.0002 |
| 3 | Cannabinoid [EPC] | 1 | 0.0001 |
| 4 | Sigma-1 Agonist [EPC] | 1 | 0.0001 |
| 5 | Opioid Agonist [EPC] | 19 | 0.0001 |
| 6 | 5-alpha Reductase Inhibitor [EPC] | 7 | 0.0001 |
| 7 | Nonergot Dopamine Agonist [EPC] | 1 | 0.0001 |
| 8 | Non-Standardized Plant Allergenic Extract [EPC] | 1 | 0.0001 |
| 9 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 6 | 0.0001 |